Stock · STE · Healthcare
United States · Large Cap · listed since 1992 · Revenue 12 mo. $6B
Price as of 11/06/2026
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Original text from the data provider
Summary
56.2 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €872.6M (2026), it supports €9.7B. The remaining €11.8B of the market value assume it grows 11.1% a year for 10 years and not at all afterwards.
Required FCF growth per year
11.1%
no growth afterwards
Price to operating cash flow 19.2×, below its usual range.
Middle half of 20 quarters: 19.3× to 25.8×, median 22.5×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
No anomaly in the stored figures.
Since the last quarter
Q1 → Q2 2026
7 more unchanged: Revenue, 12 mo., FCF, 12 mo., Gross margin, EBIT margin, Net debt, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 10.93% | 11.52% | Rank 47 |
| Return on capital (Greenblatt) | 30.90% | 32.55% | Rank 47 |
| EBIT margin | 18.56% | 18.31% | Rank 53 |
| FCF margin | 16.38% | 14.12% | Rank 56 |
| Gross margin | 44.25% | 60.99% | Rank 28 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 8.73% | 8.04% | Rank 54 |
| Earnings growth, 3 years per year | 95.31% | 5.44% | Rank 97 |
| Earnings growth, 5 years per year | 11.45% | 7.00% | Rank 61 |
| Sustainable growth (ROE × retained earnings) | 6.22% | 3.66% | Rank 77 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 3.15% | 2.90% | Rank 53 |
| FCF yield | 4.06% | 3.63% | Rank 54 |
| EV/saleslower is better | 4.31 | 4.03 | Rank 46 |
| EV/EBITlower is better | 23.23 | 21.73 | Rank 45 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | −12.59% | 8.66% | Rank 28 |
| Share price, 6 months | 22.10% | 24.27% | Rank 47 |
| Share price, 3 months | 11.38% | 15.42% | Rank 39 |
| Distance from 52-week high | −6.09% | −7.35% | Rank 55 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −0.42% | 0.30% | Rank 57 |
| Change in share countlower is better | −0.37% | 0.00% | Rank 59 |
| Dividend streak in years | 15 | 10 | Rank 74 |
| Price reaction to results, market-adjusted | −0.15% | 0.05% | Rank 47 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 66.90% | 48.40% | Rank 75 |
| Net debt/EBITDAlower is better | 1.03 | 1.11 | Rank 52 |
| Debt to equitylower is better | 0.29 | 0.48 | Rank 63 |
| Volatility, 1 yearlower is better | 26.18% | 31.42% | Rank 82 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $M | Shares | Net debt |
|---|---|---|---|---|---|
| 2017 | 2.6 | 8.7% | 251.2 | 86.1M | $1.2B |
| 2018 | 2.6 | 15.3% | 292.2 | 85.7M | $1.1B |
| 2019 | 2.8 | 14.8% | 349.8 | 85.5M | $962.6M |
| 2020 | 3.0 | 17.7% | 376.0 | 85.6M | $830.9M |
| 2021 | 3.1 | 17.7% | 450.4 | 85.9M | $1.4B |
| 2022 | 4.2 | 11.3% | 397.2 | 98.3M | $2.9B |
| 2023 | 4.5 | 17.4% | 395.0 | 100M | $2.8B |
| 2024 | 5.1 | 16.3% | 612.9 | 99.4M | $3.2B |
| 2025 | 5.5 | 15.9% | 778.0 | 99.1M | $2.0B |
| 2026 | 5.9 | 18.6% | 972.4 | 98.7M | $1.6B |
3 of 7 StockScorer Score rules met · How the score is built
STERIS plc mainly meets criteria in the Valuation category. Result from 18 strategies checked.
STERIS plc is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for STERIS plc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 31.7 | 30.0 |
| P/B ratio | 3.5 | 4.8 |
| Return on equity (ROE) | 10.9% | 11.5% |
| Equity ratio | 66.9% | 48.4% |
| Debt-to-equity (D/E) | 0.29 | 0.48 |
| Dividend yield | 1.0% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| STE | STERIS plcthis page | |
| ZBH | Zimmer Biomet Holdings Inc | Low4.5 |
| DXCM | DexCom Inc | High8.2 |
| GKOS | Glaukos Corp | locked |
| PEN | Penumbra Inc | locked |
| GEHC | GE HealthCare Technologies Inc. | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.